Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D003024:Clozapine / Q000494:pharmacology*; D003984:Dibenzazepines / Q000494:pharmacology*; D004298:Dopamine; D006220:Haloperidol / Q000494:pharmacology*; D006801:Humans; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D013239:Stereotyped Behavior / Q000187:drug effects*; D013881:Thioridazine / Q000494:pharmacology*; D013997:Time Factors
D003984:Dibenzazepines; D011955:Receptors, Drug; D003024:Clozapine; D006220:Haloperidol; D001058:Apomorphine; D013881:Thioridazine; D004298:Dopamine